LG: Did you see the Millie update? It's shaken up more than

New Post Public Reply Private Reply Replies (1) Message Board
bellsandwhistles LegalGirl #28547
LG: Did you see the Millie update? It's shaken up more than the Big Pharma state of Tennessee. The Millie Mattison case is a cause celebre with national and even international implications going forward. Big Pharma comes out of this smelling like a cesspool connected to a feedlot. When MMJ is legalized in all 50 states and the reprobates are forced by the American People to reschedule MJ, Millie Mattison will be one of the reasons why.

Segment
March 5, 2014
Penn Mattison's 2-year-old daughter, Millie, has intractable epilepsy. Her seizures (since age 2 months) were so severe the family thought they would be planning her funeral. Her parents were willing to try anything, so, in January, they moved from Tennessee to Colorado, where medical marijuana is legal. And within five weeks of taking the drug in an oil form, Mattison said it's been a miracle for his daughter. Mattison said Millie's seizures have dropped 75 percent.

"We have gone from 300 seizures a day to maybe one to 15," Mattison said.
And her medical bill has also dropped sufficiently. "The medicine we were on was roughly $60,000 a month in the state of Tennessee," the father said. "It costs us roughly $60 a month in Colorado. "

Mattison and six other medical marijuana advocates testified Wednesday before a Health sub-committee, including Toni Corbin, of Lebanon. Corbin's son, Wallace Peterson, suffered a traumatic brain injury after a motorcycle wreck. "If God made this cannabis plant and God made us with this Cannabis receptor in our bodies, maybe God has a plan. Who are we to question and interfere in God's plan?," Corbin said.

The advocates are hoping Tennessee lawmakers will pass the Koozer-Kuhn Medical Cannabis Act. They say more than 60,000 Tennesseans with chronic medical conditions are buying marijuana illegally on the streets, and several of those who testified at the hearing admitted that.  "Passing the Koozer-Kuhn Medical Cannabis Act will keep thousands of cancer patients like me from having to go to the streets for this natural medicine," said cancer patient Cathy Walker.
http://investorshangout.com/boards/message?id=1348605



"The cause of her seizures is still unknown. Millie has endured intubations, blood transfusions, spinal taps, MRIs, CAT scans, genetic testing and stints in the pediatric intensive care unit, one due to kidney shutdown from an anti-seizure ketogenic diet. She's been on as many as 11 (Big Pharma) medications at one time and relies upon a feeding tube. Her current medication, Sabril, leaves her lethargic and has severe potential side effects, including blindness."

"One study we looked at said that if two anti-epileptics don't work, there's a 10 percent chance that any of them will work," Penn says. "If four don't work, there's a 0.8 percent chance. We've been on six. Nothing has really helped that much. She sleeps 20, 22 hours a day — there's no way she can build any muscle tone or development skills."
http://investorshangout.com/boards/message?id=1185248
http://investorshangout.com/boards/message?id=1187856
http://investorshangout.com/boards/message?id=1187878
http://investorshangout.com/boards/message?id=1243166

U.S. Senator Lamarr Alexander of Tennessee, high ranking and powerful, was the fourth highest recipient of Big Pharma campaign "contributions" in 2013-2014. Tennesseans take second billing as the most over-medicated people in the US. More prescriptions per capita are written in Tennessee than in 48 states. According to Pro Publica's "Dollars for Docs," Big Pharma owns influential Tennessean medical professionals, paying them millions of dollars to salute and advocate the newest Big Pharma drugs to their fellow professionals and professional associations. In 2009, key Tennessee doctors received about $8mil for Big Pharma advocacy. In 2012 , doctors nationwide received $2 billion in direct payments and gratuities from 15 big drugmakers.


http://investorshangout.com/boards/message?id=1185172


SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 863

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 200

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 245

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 238

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 286

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 151

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading

Top 5 Most Recently Viewed Articles

Avacta Therapeutics Showcases Promising FAP-Dox Data at ESMO

Updated Category News Views 196

Avacta Therapeutics Presents FAP-Dox Data at International Congress Avacta Therapeutics, a pioneering life sciences company, is set to present an exciting update regarding their innovative drug FAP-Dox (AVA6000) at an esteemed international oncology congress. This event will spotlight groundbreaking research and clinical advancements in targeted cancer treatments that can...

Continue Reading
Qvinci and Harmonyze Join Forces to Revolutionize Franchise Coaching

Updated Category News Views 163

Strategic Collaboration Between Qvinci and Harmonyze In a remarkable development, Qvinci Software, renowned for its innovative franchise financial performance solutions, has announced a pivotal partnership with Harmonyze, an AI-driven performance coaching platform. This collaboration is designed to assist franchisors in transforming intricate financial insights into...

Continue Reading
Citi Remains Optimistic on Capgemini Amid Margin Growth

Updated Category News Views 198

Outlook for Capgemini Stock Citi analyst Balajee Tirupati has recently made adjustments to the price target for Capgemini SE (CAP:FP) (OTC: CAPMF), reducing it to €215 from €225. Despite this revision, Citi has maintained a positive stance, continuing to endorse a Buy rating for Capgemini's stock. Weaker Third-Quarter Update Capgemini's recent third-quarter report for...

Continue Reading
Beyond Oil Marks Key Milestone with Initial Shipment to T&J Oil

Updated Category News Views 252

Beyond Oil's Successful Expansion into the Australian Market Following its commitment to health and sustainability, Beyond Oil Ltd. (CSE: BOIL, OTCQB: BEOLF) has successfully delivered its first shipment of 5.4 tonnes of proprietary oil treatment products to T&J Oil Pty Ltd. This marks an important leap for the company as it steps into the Australian distribution arena,...

Continue Reading
Donaldson Partners with the Special Olympics to Inspire Change

Updated Category News Views 87

Donaldson's Commitment to Community Engagement Donaldson Company, Inc. (NYSE: DCI), a leader in innovative filtration solutions, has taken a significant step towards community engagement by announcing its partnership with the 2026 Special Olympics USA Games. This event is set to create a platform for inclusion, offering athletes with diverse abilities an opportunity to...

Continue Reading